Key facts
- Metopio’s last known valuation is $20.0M (Jan 2021).
- It has raised $8.7M across 1 recorded rounds; the latest was Early Stage VC ($6.0M) in Mar 2025.
- Notable investors include Chicago Early Growth Ventures, MATH Venture Partners, Sandalphon Capital, Straylight Capital.
- Metopio has filed 1 Form D with the SEC, most recently Mar 2025 ($6.0M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Metopio
Funding rounds
1 roundsAbout Metopio
Developer of a data analytics and visualization platform designed for community health analysis and planning purposes. The company's platform integrates curated national, state, and local datasets with interactive dashboards, mapping tools, automated workflows for community health assessments and improvement plans, AI-assisted qualitative analysis, customizable reporting functions, and collaborative data-sharing features, enabling public health departments, hospitals, and community organizations to analyze population health data and support evidence-based planning and decision-making.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2016
- Employees
- 37
- Website
- metopio.com/
- Ownership
- Privately Held (backing)
Metopio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Metopio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Metopio in its N-PORT filings yet. We sweep new filings monthly.